JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4801
Escalade
ESCA
$265M
| $535K | ﹤0.01% |
37,474
+18,560
| +98% | +$268K |
2017 Q4
28 quarters
|
|
|
CNCK
4802
Coincheck Group
CNCK
$272M
| $533K | ﹤0.01% |
+60,000
| New | +$571K |
2024 Q4
0 quarters
|
|
4803
CALL
First Majestic Silver
AG
$8.71B
| $532K | ﹤0.01% |
96,900
| – | – |
2024 Q2
2 quarters
|
|
|
CMRC
4804
Commerce.com Inc Series 1
CMRC
$269M
| $532K | ﹤0.01% |
86,894
+30,241
| +53% | +$189K |
2020 Q3
17 quarters
|
|
4805
Carlyle Secured Lending
CGBD
$733M
| $531K | ﹤0.01% |
29,629
+8,129
| +38% | +$140K |
2018 Q2
26 quarters
|
|
4806
International General Insurance
IGIC
$1.05B
| $530K | ﹤0.01% |
22,291
+5,434
| +32% | +$124K |
2024 Q1
3 quarters
|
|
4807
ProShares S&P 500 ex-Health Care ETF
SPXV
$41.4M
| $528K | ﹤0.01% |
8,288
| – | – |
2023 Q1
7 quarters
|
|
4808
ProShares Bitcoin Strategy ETF
BITO
$1.73B
| $528K | ﹤0.01% |
23,156
-2,023
| -8% | -$44.9K |
2024 Q1
3 quarters
|
|
|
CLYM
4809
Climb Bio
CLYM
$628M
| $525K | ﹤0.01% |
291,796
+279,020
| +2,184% | +$1.01M |
2024 Q2
2 quarters
|
|
4810
CALL
Alphatec Holdings
ATEC
$1.55B
| $525K | ﹤0.01% |
57,200
-12,200
| -18% | -$97.4K |
2024 Q1
3 quarters
|
|
|
NVMI
4811
Nova
NVMI
$12.6B
| $524K | ﹤0.01% |
2,663
-32,664
| -92% | -$6.28M |
2018 Q3
25 quarters
|
|
4812
Investar Holding Corp
ISTR
$405M
| $523K | ﹤0.01% |
23,830
+7,413
| +45% | +$162K |
2023 Q4
4 quarters
|
|
4813
Rocky Brands
RCKY
$350M
| $523K | ﹤0.01% |
22,931
+14,749
| +180% | +$361K |
2016 Q2
34 quarters
|
|
4814
Timothy Plan International ETF
TPIF
$266M
| $523K | ﹤0.01% |
19,661
-1,722
| -8% | -$47.3K |
2024 Q2
2 quarters
|
|
4815
Nuveen ESG Emerging Markets Equity ETF
NUEM
$435M
| $521K | ﹤0.01% |
17,952
+2,306
| +15% | +$70.2K |
2022 Q4
8 quarters
|
|
|
EQC
4816
DELISTED
Equity Commonwealth
EQC
| $519K | ﹤0.01% |
293,481
-469,899
| -62% | -$7.23M |
2013 Q2
46 quarters
|
|
4817
AMES National
ATLO
$287M
| $519K | ﹤0.01% |
31,596
+17,269
| +121% | +$299K |
2017 Q4
28 quarters
|
|
|
FFNW
4818
DELISTED
First Financial Northwest, Inc
FFNW
| $519K | ﹤0.01% |
23,912
+15,903
| +199% | +$355K |
2016 Q4
32 quarters
|
|
4819
CALL
Arrowhead Research
ARWR
$9.07B
| $519K | ﹤0.01% |
+27,600
| New | +$568K |
2024 Q4
0 quarters
|
|
|
4820
PUT
Arrowhead Research
ARWR
$9.07B
| $519K | ﹤0.01% |
+27,600
| New | +$568K |
2024 Q4
0 quarters
|
|
|
XHYF
4821
DELISTED
BondBloxx USD High Yield Bond Financial & REIT Sector ETF
XHYF
| $517K | ﹤0.01% |
13,870
-1,649
| -11% | -$62.1K |
2024 Q2
2 quarters
|
|
|
IFLN
4822
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$289M
| $517K | ﹤0.01% |
28,618
+593
| +2% | +$10.9K |
2022 Q4
8 quarters
|
|
4823
Sable Offshore Corp
SOC
$673M
| $517K | ﹤0.01% |
22,594
-97,438
| -81% | -$2.13M |
2021 Q2
14 quarters
|
|
4824
CALL
Northrop Grumman
NOC
$67.9B
| $516K | ﹤0.01% |
+1,100
| New | +$553K |
2024 Q4
0 quarters
|
|
|
GEAR
4825
DELISTED
Revelyst, Inc.
GEAR
| $516K | ﹤0.01% |
+26,814
| New | +$511K |
2024 Q4
0 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.